Pictet Asset Management (Switzerland)’s Boston Scientific BSX Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$201M	Sell	3,711,921 -219,521	-6%	-$11.5M	0.24%	117
2023 Q1	$197M	Sell	3,931,442 -127,849	-3%	-$6.03M	0.25%	122
2022 Q4	$188M	Sell	4,059,291 -20,356	-0.5%	-$881K	0.27%	113
2022 Q3	$158M	Sell	4,079,647 -437,674	-10%	-$17.6M	0.23%	133
2022 Q2	$168M	Buy	4,517,321 +104,541	+2%	+$4.26M	0.23%	129
2022 Q1	$195M	Buy	4,412,780 +76,084	+2%	+$3.3M	0.22%	139
2021 Q4	$184M	Buy	4,336,696 +205,258	+5%	+$8.63M	0.18%	160
2021 Q3	$179M	Buy	+4,131,438	New	+$183M	0.2%	148

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s BSX Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Boston Scientific (BSX) stake by 5.6% in Q2 2023, selling an estimated $11.5M and leaving 3,711,921 shares worth $201M. The position accounts for 0.24% of the portfolio, ranked #117.

Pictet Asset Management (Switzerland) first reported a position in BSX in Q3 2021 and has held it in 8 quarters since. 1,067 funds tracked by Wall St. Rank hold BSX as of Q2 2023.

Pictet Asset Management (Switzerland) held 3,711,921 shares of Boston Scientific worth $201M as of Q2 2023.
Pictet Asset Management (Switzerland) sold 219,521 Boston Scientific shares in Q2 2023, an estimated $11.5M.
Boston Scientific made up 0.24% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #117 holding.
Pictet Asset Management (Switzerland) first reported a position in Boston Scientific in Q3 2021 and has held it in 8 quarters since.
1,067 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.